Literature DB >> 16025546

Interim analysis on survival data: its potential bias and how to repair it.

Hans C van Houwelingen1, Cornelis J H van de Velde, Theo Stijnen.   

Abstract

We consider interim analyses in clinical trials or observational studies with a time-to-event outcome variable where the survival curves are compared using the hazard ratio resulting from a proportional hazards (PH) model or tested with the logrank test or another two-sample test. We show and illustrate with an example that if the PH assumption is violated, the results of interim analyses can be heavily biased. This is due to the fact that the censoring pattern in interim analyses can be completely different from the final analysis. We argue that, when the PH assumption is violated, interim analyses are only sensible if a fixed time horizon for the final analysis is specified, and at the time of the interim analysis sufficient information is available over the whole time interval up to the horizon. We show how the bias can then be remedied by introducing in the estimation and testing procedures an appropriate weighting that reflects the weights to be expected in the final analysis. The consequences for design and analysis are discussed and some practical recommendations are given. Copyright 2005 John Wiley & Sons, Ltd.

Mesh:

Year:  2005        PMID: 16025546     DOI: 10.1002/sim.2248

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  A new modeling and inference approach for the Systolic Blood Pressure Intervention Trial outcomes.

Authors:  Song Yang; Walter T Ambrosius; Lawrence J Fine; Adam P Bress; William C Cushman; Dominic S Raj; Shakaib Rehman; Leonardo Tamariz
Journal:  Clin Trials       Date:  2018-04-19       Impact factor: 2.486

2.  Estimation of treatment effect under non-proportional hazards and conditionally independent censoring.

Authors:  Adam P Boyd; John M Kittelson; Daniel L Gillen
Journal:  Stat Med       Date:  2012-07-04       Impact factor: 2.373

3.  Methodology to standardize heterogeneous statistical data presentations for combining time-to-event oncologic outcomes.

Authors:  April E Hebert; Usha S Kreaden; Ana Yankovsky; Dongjing Guo; Yang Li; Shih-Hao Lee; Yuki Liu; Angela B Soito; Samira Massachi; April E Slee
Journal:  PLoS One       Date:  2022-02-24       Impact factor: 3.240

4.  Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.

Authors:  Patricia Guyot; A E Ades; Mario J N M Ouwens; Nicky J Welton
Journal:  BMC Med Res Methodol       Date:  2012-02-01       Impact factor: 4.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.